Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

FDA expands TALZENNA plus XTANDI approval to earlier metastatic prostate cancer setting


Ris-Rez cuts progression risk by 67% in Phase III relapsed osteosarcoma trial


Sofe-M combination shows 79% response rate in platinum-sensitive ovarian cancer


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Can the New generation of perfusion technology compete or replace the conventional and widely preferred fed-batch technology?

Presented by Ankur Bhatnagar, Chief Scientific Manager of Biocon R&D
15th November 2017


Applications of industry 4.0 concepts in continuous pharmaceutical tablet manufacturing process

Presented by Dr Ravendra Singh, Research Faculty at C-SOPS, Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
27th January 2022


An impurity detected in a stability study: Did we miss anything in our E&L risk assessment?

Presented by Petra Booij, Investigator bij GlaxoSmithKline and Ward D’Autry, PhD Study Director at Nelson Labs Europe
15th March 2022


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia